Ozempic and GLP 1 Drugs Are Changing the Economy and Business Trends
In this episode of the Train Wreck Show with Perry Belcher and Emma Rainville, we break down how GLP 1 drugs, Ozempic, and weight loss drugs are creating massive shifts in the economy and reshaping future business trends, consumer behavior changes, and macro trends in business. This isn’t just about health — it’s about the Ozempic business impact, GLP 1 economic impact, and the ripple effects across industries. As adoption of GLP 1 drugs like Ozempic accelerates, we’re already seeing third order effects in the economy, from changes in restaurants, alcohol consumption, supplements and nutrition trends, meal prep business opportunities, and emerging market opportunities. This conversation focuses on how to spot disruptive trends early, understand consumer behavior shifts, and identify business opportunities before the market catches up. If you’re interested in disruptive trends 2026, healthcare disruption trends, weight loss drugs economy, Ozempic ripple effects, and macro trends in business, this episode will help you see where the next opportunities are forming — and how to position yourself ahead of them. In this conversation: • Why middle-tier restaurants could be in serious trouble • How airlines are already benefiting from lighter passengers • Why alcohol consumption may decline faster than expected • The growing opportunity in supplements and nutrition • How fashion spending could surge as people lose weight • Why meal prep businesses may make a comeback • The tipping point rule that predicts mass adoption • The unexpected rise of GLP-1 use cases (including pets) • How longer lifespans could disrupt retirement models This isn’t really about Ozempic. It’s about learning how to see opportunity when the world shifts. Resources: Website – https://trainwreckshow.com Join the Driven Mastermind – https://drivenmastermind.com/ Join the Ignite Mastermind – https://ignitemastermind.org/ Workshops, GPTs, and Other Resources – https://trainwreckshow.com/companion-... Connect with Perry Belcher: 🌐 Website – https://ignitemastermind.org/ 👤 Facebook – / theperrybelcher 📷 Instagram – / perry.belcher ▶️ YouTube – / @perrybelcher Connect with Emma Rainville: 🌐 Website – https://www.shockwavesolutionsllc.com/ 👤 Facebook – / queenofops 📷 Instagram – / emma_rainville512

Eli Lilly CEO: How GLP-1s Will Reshape America

Forget Zepbound: 15 New Obesity Drugs Are Coming

Ozempic & Mounjaro: Same Shot. Opposite Results.

Dr. Terry Dubrow on Ozempic, Peptides & Non-Surgical Anti-Aging for Longevity

Trump Crashes Spain's World Cup Moment & Jon Examines Team Trump's “Meritocracy" | The Daily Show

Unmasking Belle Gibson: The real story of the infamous wellness scammer | 60 Minutes Australia

WTF Is Happening to South Korea

I'm a Pathologist. Ozempic & Mounjaro Aren't Actually Weight Loss Drugs.

Angel Strawbridge on 'Escape to the Chateau' Controversy, Dyslexia and Finding True Love

50% of Patients May NEVER Get GLP-1s? Lilly CEO Drops Bombshell!

The Ultimate GLP-1 Guide: Weight Loss, Side Effects & Sarcopenia Risk

"good health" has become a competition

I Made 7 GLP-1 Mistakes (So You Don't Have To)

10 Ozempic Diet Mistakes That RUIN Your Weight Loss (AVOID These Foods)

Alexander Family Practice: Small Town Big Business Podcast

The 10 Best Foods That Make Ozempic & Zepbound Work FASTER! Weight Loss Doctor Explains

Serena Williams and Oprah on Deciding to Take GLP-1 Medications

Why Novo Nordisk Had to Cut Ozempic's Price in Canada

How A Single Hedge Fund Killed Chipotle

